Vaccine 4 1 1 for 7-20-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

On this episode of Vaccine 411……Can cannabis calm the Cytokine Storm?

First, the latest vaccine news from around the world:

United States: Kentucky BioProcessing has entered Phase I clinical trials for their tobacco-based vaccine. The tobacco plant is engineered to make viral proteins.

 107,000 people have signed up for clinical trials for a COVID-19 vaccine, at least 120,00 are needed by the fall for Phase III trials for 4 potential vaccines. 

United Kingdom: Oxford University/Astra Zeneca released positive data on their early stage trials, noting that it has produced promising response in large early stage trials. They are currently in Phase III trials in the UK, Brazil & South Africa and will begin a U.S. trial soon. 

The UK has secured an additional 90 million doses of potential COVID-19 vaccines by partnering with BioNtech/Pfizer and Valneva. This is in addition to their partnership with University of Oxford/AstraZeneca. 

Synairgen, announced they may have a potential new treatment for COVID-19. The Southampton based biotech company presented research that their inhaled drug lowered the risk of a severe case of COVID-19 by 79%, reports The Washington Post. The study has not been peer reviewed. 

North Korea: The State Commission of Science and Technology posted on their website that they have started Phase I clinical trials on a vaccine candidate. Though no data was provided.  

Hosted on Acast. See acast.com/privacy for more information.